Wanbangde Pharmaceutical Holding Group Co.,Ltd.’s Net Profit Dropped 53.9% in 2022

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) (002082.SZ) reported a net profit of 74.3 million yuan in 2022, down 53.9% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, down 7.5% year-on-year.

At the end of the reporting period, it had 4.2 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 33.1%.